Posted by Friends of FSH Research on Aug 23, 2022
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD (ReSolve FSHD)
-Enrollment has reached 90% worldwide, 100% in the US
-Anonymous poll regarding your interest in future research participation
-Enrollment for MOVE FSHD ends by December 2022
-MOVE+ Sub-study information
See CTRN Newsletter
Connect with us on social media